These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38862526)
1. An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis. Teng JS; Wang Y Sci Rep; 2024 Jun; 14(1):13401. PubMed ID: 38862526 [TBL] [Abstract][Full Text] [Related]
2. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma. Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858 [TBL] [Abstract][Full Text] [Related]
3. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma. He L; Yang H; Huang J BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089 [TBL] [Abstract][Full Text] [Related]
4. Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma. Chen Y; Zhao B; Wang X BMC Cancer; 2020 Oct; 20(1):1022. PubMed ID: 33087099 [TBL] [Abstract][Full Text] [Related]
5. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma. Wu G; Zhang M BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271 [TBL] [Abstract][Full Text] [Related]
6. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients. Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792 [TBL] [Abstract][Full Text] [Related]
7. A five metastasis-related long noncoding RNA risk signature for osteosarcoma survival prediction. Yu S; Shao F; Liu H; Liu Q BMC Med Genomics; 2021 May; 14(1):124. PubMed ID: 33964903 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes. Qi W; Yan Q; Lv M; Song D; Wang X; Tian K Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109 [No Abstract] [Full Text] [Related]
9. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children. Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075 [TBL] [Abstract][Full Text] [Related]
10. Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma. Liu D; Hu Z; Jiang J; Zhang J; Hu C; Huang J; Wei Q Sci Rep; 2022 Jan; 12(1):1617. PubMed ID: 35102149 [TBL] [Abstract][Full Text] [Related]
11. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma. Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832 [TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. Lei T; Qian H; Lei P; Hu Y Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683 [TBL] [Abstract][Full Text] [Related]
13. Identification of TNFRSF1A as a potential biomarker for osteosarcoma. Zhang Y; Liu K; Wang J Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759 [TBL] [Abstract][Full Text] [Related]
14. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts. Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients. Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645 [TBL] [Abstract][Full Text] [Related]
16. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma. Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497 [TBL] [Abstract][Full Text] [Related]
17. Development of an immune-related prognostic index associated with osteosarcoma. Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients. Yang M; Ma X; Wang Z; Zhang T; Hua Y; Cai Z Aging (Albany NY); 2021 May; 13(9):12896-12918. PubMed ID: 33952718 [TBL] [Abstract][Full Text] [Related]
19. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value. Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279 [TBL] [Abstract][Full Text] [Related]
20. A novel prognostic signature related to programmed cell death in osteosarcoma. Jiang YC; Xu QT; Wang HB; Ren SY; Zhang Y Front Immunol; 2024; 15():1427661. PubMed ID: 39015570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]